895 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Carcinoma, Bronchogenic" (895 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
3 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
4 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
5 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
6 Not yet recruiting Safety & Efficacy Study of EGF Cancer Vaccine to Treat Stage IV Biomarker Positive, Wild Type EGF-R NSCLC Patients
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Biological: EGF Vaccine
7 Unknown  ABX Combined With Cisplatin Compared With Gemcitabine Combined With Cisplatin in NSCLC
Condition: Non Small Cell Lung Cancer
Interventions: Drug: ABX Combined With Cisplatin;   Drug: Gemcitabine Combined With Cisplatin
8 Recruiting Intergroup Trial UNICANCER UC 0105-1305/ IFCT 1301: Efficacy of Targeted Drugs Guided by Genomic Profils in Metastatic NSCLC Patients
Condition: Non-small Cell Lung Cancer Metastatic
Interventions: Drug: AZD2014;   Drug: AZD4547;   Drug: AZD5363;   Drug: AZD8931;   Drug: Selumetinib;   Drug: Vandetanib;   Drug: Erlotinib;   Drug: Pemetrexed
9 Recruiting Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional Fractionation
Condition: Non-Small Cell Lung Cancer
Interventions: Radiation: conventional fractionation;   Radiation: accelerated fraction
10 Unknown  Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention: Drug: SB injection
11 Recruiting Expression of Met Receptor Fragments in Non Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention: Other: Met analysis on tissue and blood
12 Not yet recruiting Safety, Pharmacokinetic and Preliminary Efficacy Study of Avitinib in Patients With Definitely EGFR T790M State NSCLC
Condition: Non-small Cell Lung Cancer Metastatic
Intervention: Drug: Avitinib
13 Recruiting Oligometastatic Disease
Condition: Lung Cancer
Interventions: Other: No LCT;   Other: LCT
14 Recruiting Trial of Erlotinib and BKM120 in Patients With Advanced Non Small Cell Lung Cancer Previously Sensitive to Erlotinib
Condition: Non Small Cell Lung Cancer
Intervention: Drug: BKM120 and Erlotinib
15 Unknown  Pharmacodynamic Separation of Pemetrexed and Erlotinib as Second-line Therapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Pemetrexed;   Drug: pemetrexed and erlotinib
16 Recruiting A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations
Condition: ALK Positive Non Small Cell Lung Cancer
Intervention: Drug: PF-06463922
17 Recruiting Systemic Treatment of Resistant Metastatic Disease
Conditions: Non-small Cell Lung Cancer;   Castrate-resistant Prostate Cancer;   Melanoma;   Bladder Cancer
Intervention: Biological: CVA21
18 Unknown  Validation of the MiCK Assay
Condition: Mesothelioma, Small Cell Lung Cancer, NSCLC
19 Recruiting Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC
Conditions: Non-small Cell Lung Cancer Metastatic;   EGFR Activating Mutation
Interventions: Drug: Gefitinib;   Drug: gemcitabine;   Drug: carboplatin
20 Recruiting AVAdeno Study: An Observational Study of First-Line Avastin (Bevacizumab) in Patients With Adenocarcinoma of the Lung
Condition: Non-Small Cell Lung Cancer

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years